Developing oral chemotherapies and kinase inhibitors for cancer in the US/China.
Industry: Health Care
First Day Return: +14.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/12/2017 |
Offer Price | $11.00 |
Price Range $11.00 - $13.00 | |
Offer Shares (mm) | 6.0 |
Deal Size ($mm) | $66 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/13/2017 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $66 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Buffalo, NY, United States |
Founded | 2003 |
Employees at IPO | 429 |
Website www.athenex.com |